The $110 Billion Catalyst That Could Propel Oracle Cloud Growth to 2030
Oracle has big cloud plans, aiming for massive revenue growth by 2030. A pivotal $110 billion catalyst could make tha...
What To Consider For Retirement In Your 30s
Learn what to consider for retirement in your 30s to effectively build wealth and secure your financial future. Start making informed choices now!
18,719 articles
Venezuela World’s Largest Proven Oil Fails Hormuz Puzzle
Global oil markets face a stubborn constraint: even the venezuela world’s largest proven oil reserves can't offset th...
Federal Reserve Holds Benchmark Rate Amid War Uncertainty
The Federal Reserve kept the benchmark rate unchanged in a policy decision this week. Officials say fallout from wart...
Under-$1 Pre-IPO AI Investment Still Open for Retail
A private AI startup is offering a sub-$1 pre-IPO round open to retail investors, pricing shares at $0.66 and promisi...
Years Wars Show They Are Disaster Times for Debt Holders
A 300-year cross-Atlantic study shows government bonds often lose real value during wars and major emergencies, a pat...
U.S. Deploying More Amphibious Ships Stirs Markets Today
The U.S. is expanding its military footprint in the Middle East, adding three amphibious ships and 2,500 Marines. Mar...
Gold Price Free-Falling: Golden Test for Safe-Haven Demand
Gold prices slide as liquidity fades and risk appetite shifts, forcing traders to rethink the king of safe havens and...
Fed Rate Hikes Debate, Credit Tightening Sparks Markets
Credit conditions are tightening ahead of any Fed move, driven by higher bond yields and a wave of AI financing. Inve...
Billionaire OpenAI Investor Vinod Warns 2030 Job Takeover
A leading AI investor says up to 80% of jobs could be AI-enabled by 2030, a view that’s fueling a new wave of policy ...
These U.S. Weapons Were So Powerful They Pushed Limits
As defense budgets stabilize and technology explodes, investors are re-pricing defense names. This piece examines why...
Fundrise Fund Falls Mania: VCX Slumps 45% as IPO Mania Fades
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status